首页> Blood advances> <i>NPM1</i> mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy.

<i>NPM1</i> mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Guillermo,Montalban-Bravo

第一单位： Department of Leukemia and.

作者： Guillermo,Montalban-Bravo ^[1] ; Rashmi,Kanagal-Shamanna ^[2] ; Koji,Sasaki ^[1] ; Keyur,Patel ^[2] ; Irene,Ganan-Gomez ^[1] ; Elias,Jabbour ^[1] ; Tapan,Kadia ^[1] ; Farhad,Ravandi ^[1] ; Courtney,DiNardo ^[1] ; Gautham,Borthakur ^[1] ; Koichi,Takahashi ^[1] ; Marina,Konopleva ^[1] ; Rami S,Komrokji ^[3] ; Amy,DeZern ^[4] ; Teodora,Kuzmanovic ^[5] ; Jaroslaw,Maciejewski ^[5] ; Sherry,Pierce ^[1] ; Simona,Colla ^[1] ; Mikkael A,Sekeres ^[5] ; Hagop,Kantarjian ^[1] ; Carlos,Bueso-Ramos ^[2] ; Guillermo,Garcia-Manero ^[1]

作者单位： Department of Leukemia and. ^[1] Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX. ^[2] Malignant Hematology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL. ^[3] Department of Hematology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; and. ^[4] Department of Hematology and Medical Oncology Research, Cleveland Clinic, Cleveland, OH. ^[5]

医学主题词成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);高通量核苷酸序列分析(High-Throughput Nucleotide Sequencing);人类(Humans);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);中年人(Middle Aged);突变(Mutation);骨髓增生异常综合征(Myelodysplastic Syndromes);骨髓增生异常-骨髓增殖性疾病(Myelodysplastic-Myeloproliferative Diseases);核蛋白质类(Nuclear Proteins);缓解诱导(Remission Induction);回顾性研究(Retrospective Studies);存活率分析(Survival Analysis);治疗结果(Treatment Outcome);青年人(Young Adult)

DOI 10.1182/bloodadvances.2018026989

PMID 30902805

发布时间 2021-12-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览4

Blood advances

2019年3卷6期

922-933页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览4

点击下载本期目录封面

Blood advances

2019年3卷6期

922-933页

检索历史清除

<i>NPM1</i> mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy.

Blood advances

相似文献

同项目论文

Blood advances

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

<i>NPM1</i> mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy.

Blood advances

相似文献

同项目论文

Blood advances

相关期刊

检索历史清除